Remove Atherosclerosis Remove Biomarkers Remove Diet
article thumbnail

Roche's Lp(a) Gen.2 Molarity Assay Receives FDA Clearance

DAIC

This clearance comes in advance of disease-modifying therapies on the horizon expected to help clinicians use this biomarker to guide patients to improved cardiovascular health, saidBrad Moore, president and CEO at Roche Diagnostics North America. The development of the Tina-quant Lipoprotein (a) Gen.2 2022 Aug, 80 (9) 934946 Kronenberg F.

article thumbnail

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1) 

Cardiometabolic Health Congress

A meta-analysis published in the Journal of Consulting and Clinical Psychology found that motivational interviewing effectively promoted behavior change across various health domains, including diet and exercise. Key contributions: Advanced cardiac imaging (e.g., Key contributions: Advanced cardiac imaging (e.g.,

article thumbnail

The Ultimate Guide to Sleep and Cardiovascular Health

Physiologically Speaking

The amount of calcium in the blood vessels (known as arterial calcification), a marker of subclinical atherosclerosis, is higher in people with a short sleep duration. 14 One study of over 1,900 men found evidence that very short sleep duration predicts a higher burden of atherosclerosis in their coronary and femoral arteries.

article thumbnail

Lifestyle Risk Factors Predict Coronary Calcification among Male Endurance Athletes

Physiologically Speaking

Coronary artery calcium (CAC) is a measure of atherosclerosis and a strong predictor of cardiovascular disease. The Latest Evidence on Atherosclerosis in Athletes The risk factor component is yet unexplored—how do risk factors other than training contribute to elevated CAC in endurance athletes?